Knowledge Content
#### 1. Biochemical Level: Estrogen Inhibition Initiated within 24 Hours
https://www.fiercerawsource.com/steroid-finished/steroid-finished-tablets/stromusc-pills-1mg-arimidex-anastrozole-100.html
Plasma concentrations reach peak within 1-2 hours after oral administration. Within 24 hours, it inhibits aromatase activity in peripheral tissues (such as adipose and adrenal glands) by over 80%, reducing estradiol (E2) levels by 40%-50%. This rapid blocking effect is due to its irreversible binding mechanism-covalently binding to the active site of aromatase to form a stable complex. This inhibitory effect does not require sustained high concentrations to be maintained. By the third day of dosing, estradiol levels can reach a steady-state trough (a 70%-80% decrease from baseline), laying the foundation for clinical efficacy.
#### 2. Clinical Effects: Differentiated Response Rates Across Scenarios
- **Anti-estrogen Side Effects**: When used by fitness enthusiasts to counteract estrogen conversion from testosterone, water and sodium retention (such as facial edema) is significantly alleviated within 3-5 days. This improved fluid metabolism reduces joint pressure during training. Symptoms such as acne and areolar hyperpigmentation gradually resolve within 1-2 weeks, once the residual estrogen in the skin and hair follicles is metabolized.
- **Adjuvant Therapy**: In the treatment of hormone-sensitive breast cancer, bone density preservation takes 4-6 weeks (due to the longer bone metabolism cycle). Menopausal symptoms such as hot flashes and night sweats may initially worsen within 1 week due to the sudden drop in estrogen levels, then gradually subside over the next 2-3 weeks, demonstrating a "suppression followed by stabilization" effect.
#### 3. Maintenance of Effects After Onset
After reaching steady state (1 mg daily for 7 consecutive days), the estradiol-suppressing effect is maintained. After discontinuation, estrogen levels gradually recover over 5-7 days due to aromatase resynthesis. This underpins the principle of sustained estrogen control with a "once-daily" dose, avoiding fluctuations in efficacy due to dosage fluctuations.
